Biogened (WAR:BGD) Inventories, Work In Process: zł0.6 Mil (As of Mar. 2026)


WAR:BGD Biogened SA WAR:BGD
68 GF Score
Price zł18.40
GF Value zł23.80
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Biogened Inventories, Work In Process?

Biogened WAR:BGD 68 Inventories, Work In Process is zł0.6 Mil as of Mar. 2026. GuruFocus rates WAR:BGD with a GF Score™ of 68/100 and a GF Value™ of zł23.80 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Biogened's work in process for the quarter that ended in Mar. 2026 was zł0.6 Mil.

Biogened Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Biogened's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biogened Inventories, Work In Process Chart

Biogened Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.43 0.24 0.62 0.23

Biogened Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.25 0.29 0.23 0.62
WAR:BGD
68GF Score
Biogened SA WAR:BGD
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biogened Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of zł0.6 Mil mean?
Biogened (WAR:BGD) has a Inventories, Work In Process of zł0.6 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Biogened and its competitors.
Is Biogened's Inventories, Work In Process too high?
Biogened's current Inventories, Work In Process is zł0.6 Mil. Overall, Biogened has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Biogened's Inventories, Work In Process compare to ZTS and UTHR?
Biogened's Inventories, Work In Process of zł0.6 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Drug Manufacturers company?
A good Inventories, Work In Process depends on the Drug Manufacturers industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Biogened and its competitors. Biogened's current Inventories, Work In Process is zł0.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biogened stock overvalued right now?
Based on GuruFocus' analysis, Biogened (WAR:BGD) is currently considered Modestly Undervalued. The stock's GF Value™ is zł23.80, compared to a current price of zł18.40 — trading 22.7% below its estimated fair value. The current Inventories, Work In Process is zł0.6 Mil. Biogened's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Biogened (WAR:BGD), the current Inventories, Work In Process is zł0.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biogened (WAR:BGD) Overvalued in 2026?

Based on GuruFocus' analysis, Biogened stock appears to be undervalued. The current stock price of zł18.40 is trading 22.7% below its estimated GF Value™ of zł23.80. GuruFocus considers Biogened to be Modestly Undervalued.

Key valuation signals for WAR:BGD:

  • Inventories, Work In Process: zł0.6 Mil
  • GF Value™: zł23.80 vs. price of zł18.40 (22.7% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the WAR:BGD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biogened Business Description

Address Ulica Pojezierska 99, Lodz, POL, 91-342
Biogened SA is involved in manufacturing cosmetic and hygiene products. It also designs, produces, and markets safe, effective dermo-cosmetics under the Dermedic brand. The company's products include Dermocosmetics, Thermal water, and Pharmaceutical manufacturing conditions.
68GF Score

Get the complete analysis for WAR:BGD

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł18.40
Price
zł23.80
GF Value